InsidersTradesSigma
Follow the ARATANA THERAPEUTICS, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 2 February 2016 (Cession). Among the most active insiders: TOOMAN CRAIG A. Every trade is free.
Analysts rate ARATANA THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
ARATANA THERAPEUTICS, INC. is a biopharmaceutical company focused on developing therapeutic products for companion animals. The company is listed on NASDAQ under the ticker symbol PETX.